Staidson (beijing) Biopharmaceuticals Co., Ltd
Clinical trials sponsored by Staidson (beijing) Biopharmaceuticals Co., Ltd, explained in plain language.
-
New drug trial aims to tame dangerous autoimmune attack
Disease control Recruiting nowThis study is testing whether adding an investigational drug called BDB-001 to standard treatments helps people with ANCA-associated vasculitis (AAV) achieve and maintain remission. AAV is a serious autoimmune disease where the body's immune system attacks its own small blood ves…
Phase: PHASE3 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Apr 04, 2026 06:51 UTC
-
New injection tested for male fertility issue
Disease control Recruiting nowThis early-stage study is testing the safety and how the body processes a new drug called STSP-0902. It involves healthy men who have a low sperm count. Researchers will give different doses to small groups to see how well it is tolerated before testing if it can help improve spe…
Phase: PHASE1 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug trial aims to save lives from severe lung failure
Disease control Recruiting nowThis study is testing an investigational drug called STSA-1002 for patients with Acute Respiratory Distress Syndrome (ARDS), a life-threatening form of lung failure. It will compare the drug against a placebo in about 406 hospitalized patients to see if it improves survival and r…
Phase: PHASE3 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC